Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Managing portal hypertension in patients with liver cirrhosis

Sauerbruch T, Schierwagen R, Trebicka J.

F1000Res 2018 , 7: F1000 Faculty Rev-533

DOI: 10.12688/f1000research.13943.1

Acute-on-chronic liver failure, human serum albumin, and immune modulation: The beginning of an exciting adventure

Arroyo V, Clària J.

Clin Gastroenterol Hepatol 2018, 16(5): 633–636

DOI: 10.1016/j.cgh.2017.12.008

Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis

Simón-Talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-Martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J; Baveno VI-SPSS group from the Baveno Cooperation

Gastroenterology 2018, 154(6): 1694–1705.e4

DOI: 10.1053/j.gastro.2018.01.028

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis

Ruiz-Margáin A, Pohlmann A, Ryan P, Schierwagen R, Chi-Cervera LA, Jansen C, Mendez-Guerrero O, Flores-García NC, Lehmann J, Torre A, Macías-Rodríguez RU, Trebicka J.

Liver Transpl 2018, 24(5): 595–605

DOI: 10.1002/lt.25041

Severe abnormal heart rate turbulence onset is associated with deterioration of liver cirrhosis

Jansen C, Al-Kassou B, Lehmann J, Pohlmann A, Chang J, Praktiknjo M, Nickenig G, Strassburg CP, Schrickel JW, Andrié R, Linhart M, Trebicka J.

PLoS One 2018, 13(4): e0195631

DOI: 10.1371/journal.pone.0195631

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis

Mohr R, Boesecke C, Dold L, Schierwagen R, Schwarze-Zander C, Wasmuth JC, Weisensee I, Rockstroh JK, Trebicka J.

Medicine 2018, 97(17): e0462

DOI: 10.1097/MD.0000000000010462

“Tipping” extracellular matrix remodeling towards regression of liver fibrosis: Novel concepts

Magdaleno F, Schierwagen R, Uschner FE, Trebicka J.

Minerva Gastroenterol Dietol 2018, 64(1): 51–61

DOI: 10.23736/S1121-421X.17.02442-4

Cell death markers in patients with cirrhosis and acute decompensation

Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, Zheng YB, Gronbaek H, Gerbes AL, Sola E, Caraceni P, Moreau R, Gines P, Arroyo V, Jalan R.

Hepatology 2018, 67(3): 989–1002

DOI: 10.1002/hep.29581

Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma

Praktiknjo M, Krabbe V, Pohlmann A, Sampels M, Jansen C, Meyer C, Strassburg CP, Trebicka J, Gonzalez Carmona MA.

PLoS One 2018, 13(2): e0192897

DOI: 10.1371/journal.pone.0192897

Does transjugular intrahepatic portosystemic shunt stent differentially improve survival in a subset of cirrhotic patients?

Trebicka J.

Semin Liver Dis 2018, 38(1): 87–96

DOI: 10.1055/s-0038-1627457

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024